Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma:an efficacy and cost-effectiveness study

References

• Goldsmith DR, Keating GM. Budesonide/formoterol: a review of its use in asthma. Drugs 2004;64:1597–618
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Löfdahl C-G, Postma DS, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. New Engl J Med 1997;337:1405–11
   PubMed Web of Science ®Google Scholar
• Foresi A, Morelli MC, Catena E. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. Chest 2000;117:440–6
   Google Scholar
• FitzGerald JM, Becker A, Sears MR, et al. Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations. Thorax 2004;59:550–6
   PubMed Web of Science ®Google Scholar
• Harrison TW, Oborne J, Newton S, Tattersfield AE. Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial. Lancet 2004;363:271–5
   PubMed Web of Science ®Google Scholar
• Ellul-Micallef R. The acute effects of corticosteroids in bronchial asthma. Eur J Respir Dis 1982;63(Suppl 122):118–25
   Google Scholar
• Ringdal N, Derom E, Wåhlin-Boll E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler. Respir Med 1998 92:1017–21
   Google Scholar
• Ställberg B, Olsson P, Jörgensen LA, et al. Budesonide/formoterol adjustable maintenance dosing reduces asthma exacerbations versus fixed dosing. Int J Clin Pract 2003;57:656–61
   Google Scholar
• FitzGerald JM, Sears MR, Boulet L-P, et al. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study. Can Respir J 2003; 10:427–34
   Google Scholar
• Aalbers R, Backer V, Kava TTK, et al. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma. Curr Med Res Opin 2004;20:225–40
   PubMed Web of Science ®Google Scholar
• Gibson PG. Teaching old drugs new tricks: asthma therapy adjusted by patient perception or non-invasive markers. Eur Respir J 2005;25:397–9
   PubMed Web of Science ®Google Scholar
• Balanag VM, Yunus F, Yang P-C, Jorup C. Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma. Pulm Pharmacol Ther 2006;19:139–47
   Google Scholar
• van der Woude HJ, Boorsma M, Bergqvist PBF, et al. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction. Pulm Pharmacol Ther 2004;17:89–95
   PubMed Web of Science ®Google Scholar
• Scicchitano R, Aalbers R, Ukena D, et al. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma. Curr Med Res Opin 2004;20:1403–18
   PubMed Web of Science ®Google Scholar
• Rabe KF, Pizzichini E, Ställberg B, et al. Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial. Chest 2006;129:246–56
   Google Scholar
• O’Byrne PM, Bisgaard H, Godard PP, et al. Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma. Am J Respir Crit Care Med 2005;171:129–36
   Google Scholar
• Vogelmeier C, D’Urzo A, Pauwels R, et al. Budesonide/ formoterol maintenance and reliever therapy: an effective asthma treatment option? Eur Respir J 2006;26:819–28
   Web of Science ®Google Scholar
• FitzGerald JM, Boulet L-P, Follows RMA. The CONCEPT trial: a 1-year, multicenter, randomized, double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/ fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma. Clin Ther 2005;27: 393–406
   Google Scholar
• Pauwels RA, Sears MR, Campbell M, et al. Formoterol as relief medication in asthma: a worldwide safety and effectiveness trial. Eur Respir J 2003;22: 787–94
   Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:2225–44
   Google Scholar
• Juniper EF, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. Eur Respir J 1999;14:902–7
   PubMed Web of Science ®Google Scholar
• Juniper EF, O’Byrne PM, Roberts JN. Measuring asthma control in group studies: do we need airway calibre and rescue beta(2)-agonist use? Respir Med 2001;95:319–23
   PubMed Web of Science ®Google Scholar
• Juniper EF, Ståhl E, O’Byrne PM. Minimal important difference for the asthma control questionnaire. Am J Respir Crit Care Med 2001;163:A642
   Google Scholar
• Juniper EF, Guyatt GH, Epstein RS, et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992;47:76–83
   PubMed Web of Science ®Google Scholar
• Juniper EF, Buist AS, Cox FM, et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999;115:1265–70
   PubMed Web of Science ®Google Scholar
• Juniper EF, Guyatt GH, Feeny DH, et al. Measuring quality of life in children with asthma. Qual Life Res 1996; 5:35–46
   PubMed Web of Science ®Google Scholar
• Ståhl E, Campbell J, Partridge M, et al. Development of an instrument to assess patient satisfaction with asthma treatment. Am J Respir Crit Care Med 2002;165:A319
   Google Scholar
• Campbell JL, Kiebert GM, Partridge MR. Development of the satisfaction with inhaled asthma treatment questionnaire. Eur Respir J 2003;22:127–34
   Google Scholar
• Andersson F, Kjellman M, Forsberg G, et al. Comparison of cost-effectiveness of budesonide Turbuhaler and sodium cromoglycate Spinhaler in the management of childhood asthma in everyday clinical practice. Ann Allergy Asthma Immunol 2001;86:537–44
   PubMed Web of Science ®Google Scholar
• Andersson F, Kartman B. Cost of angina pectoris in Sweden. PharmacoEconomics 1995;8:233–44
   PubMed Web of Science ®Google Scholar